Compare Pfizer Inc (PFE) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Wolfspeed Inc — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Wolfspeed Inc trades at $29.35 (market cap $1.65B). The key difference: Pfizer Inc is far larger — about 86.1× Wolfspeed Inc's market cap, and Pfizer Inc pays a 6.9% dividend while Wolfspeed Inc pays none. Which is the better fit depends on your goals.
| PFE | WOLF | |
|---|---|---|
Market Cap | $142.14B | $1.65B |
Volume | 29,869,932 | — |
Sector | Health | Technology |
52-Week High | $28.56 | $73.68 |
52-Week Low | $23.29 | $1.19 |
Enterprise Value | $192.80B | $2.31B |
Dividend Yield | 6.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.75, down 1.2% on the day, with a neutral technical outlook. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $0.75 beating expectations of $0.722. Pfizer demonstrates robust profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated from pandemic peaks. Recent news highlights the company's focus on AI drug discovery and pipeline development.
Pfizer presents a value opportunity trading below analyst consensus target of $28.25, with 38% of analysts rating it Buy. The stock offers a solid dividend yield with recent $0.43 payments. Key risks include patent expirations and revenue normalization post-COVID, while catalysts include obesity and oncology pipeline developments in 2026.
Wolfspeed (WOLF) trades at $29.38, down 1.71% on the day, with a bearish technical outlook driven by moving averages but oversold RSI readings. The company shows negative profitability metrics, including a gross margin of -26.63% and net income margin of -79.83%, though it beat EPS estimates in two of the last three quarters. Recent news highlights strategic moves into data centers and defense, alongside a patent lawsuit against Navitas Semiconductor.
The outlook is mixed, with analyst consensus leaning neutral (47
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
